Therapeutic management of metastatic medullary thyroid carcinoma: Role of new tyrosine kinase inhibitors

被引：0
|
作者：
Garcia-Martin, Antonia [1 ]
Lopez-Ibarra Lozano, Pablo Jose [1 ]
Maria Trivino-Ibanez, Eva [1 ]
Escobar-Jimenez, Fernando [1 ]
机构：
[1] Hosp Univ San Cecilio, Serv Endocrinol & Nutr, Granada, Spain
来源：
ENDOCRINOLOGIA Y NUTRICION | 2013年 / 60卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [1] Management of advanced stage medullary thyroid carcinoma. Therapy with tyrosine kinase inhibitors
    Raue, F.
    Fassnacht, M.
    Fuehrer, D.
    Frank-Raue, K.
    Luster, M.
    Kreissl, M. C.
    Mueller, S.
    Musholt, T.
    Ruessel, J.
    Schott, M.
    Spitzweg, C.
    Tiedje, V.
    ONKOLOGE, 2014, 20 (06): : 591 - 597
  • [2] ROLE OF TYROSINE KINASE INHIBITORS IN CHILDREN WITH MEN2 ASSOCIATED MEDULLARY THYROID CARCINOMA
    Myers, Katherine
    Akshintala, Srivandana
    Del Rivero, Jaydira
    Walker, Kim
    Widemann, Brigitte
    Glod, John
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S115 - S116
  • [3] Use of Tyrosine-Kinase Inhibitors in Medullary Thyroid Carcinoma: An Institutional Experience
    Luca, R.
    O'Connor, J. M.
    Falco, A.
    Do Pico, F.
    Tsou, F.
    Rivero, S.
    Chacon, M.
    Chacon, R.
    NEUROENDOCRINOLOGY, 2017, 105 : 218 - 218
  • [4] Kinase inhibitors for advanced medullary thyroid carcinoma
    Schlumberger, Martin
    Massicotte, Marie-Helene
    Nascimento, Camila L.
    Chougnet, Cecile
    Baudin, Eric
    Leboulleux, Sophie
    CLINICS, 2012, 67 : 125 - 129
  • [5] Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors
    Sandblom, Viktor
    Spetz, Johan
    Shubbar, Emman
    Montelius, Mikael
    Stahl, Ingun
    Swanpalmer, John
    Nilsson, Ola
    Forssell-Aronsson, Eva
    PLOS ONE, 2020, 15 (05):
  • [6] Sorafenib in the Management of Metastatic Medullary Thyroid Carcinoma
    Seow, Cherng Jye
    Yeo, Pei Shan
    Ho, Wen Yang Benjamin
    Lee, Kok Seng Melvin
    Lim, Dao Ming Gerard
    Eu, Kar Mun
    Tan, Seng Kiong
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [7] Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer
    Hadoux, Julien
    Schlumberger, Martin
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 335 - 347
  • [8] Therapeutic Drug Monitoring for Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma
    Henriksen, Jakob N.
    Andersen, Charlotte U.
    Fristrup, Niels
    CLINICAL GENITOURINARY CANCER, 2024, 22 (03)
  • [9] How to Incorporate New Tyrosine Kinase Inhibitors in the Treatment of Patients With Medullary Thyroid Cancer
    Haddad, Robert I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3618 - 3620
  • [10] Inhibition. of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors
    Cohen, MS
    Hussain, HB
    Moley, JF
    SURGERY, 2002, 132 (06) : 960 - 966
12345